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Abstract
Understanding the function of important DNA elements in mammalian stem cell genomes would be enhanced by the
availability of deletion collections in which segmental haploidies are precisely characterized. Using a modified Cre-loxP–
based system, we now report the creation and characterization of a collection of ,1,300 independent embryonic stem cell
(ESC) clones enriched for nested chromosomal deletions. Mapping experiments indicate that this collection spans over 25%
of the mouse genome with good representative coverage of protein-coding genes, regulatory RNAs, and other non-coding
sequences. This collection of clones was screened for in vitro defects in differentiation of ESC into embryoid bodies (EB).
Several putative novel haploinsufficient regions, critical for EB development, were identified. Functional characterization of
one of these regions, through BAC complementation, identified the ribosomal gene Rps14 as a novel haploinsufficient
determinant of embryoid body formation. This new library of chromosomal deletions in ESC (DelES: http://bioinfo.iric.ca/
deles) will serve as a unique resource for elucidation of novel protein-coding and non-coding regulators of ESC activity.
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Introduction
Mammalian genomes and ESC characteristics
Mouse ESCs, derived from the inner cell mass of the blastocyst
[1,2], are a lineage of choice to perform functional genomic studies
for several reasons. First, ESCs constitute a sustained source of
starting material since they indefinitely self-renew symmetrically in
defined culture conditions, generating two functionally identical
daughter cells per division [3]. Second, pluripotent ESCs enable the
study of most developmental processes in vivo or in vitro, owing to
their capacity to make all somatic cell types, including germ cells
[4,5]. Third, ESCs can model various aspects of tumorigenesis.
Undifferentiated ESCs are characterized by the absence of a robust
G1/S cell cycle checkpoint [6], a feature frequently observed in
tumor cells [7]. Moreover, ESCs are tumorigenic when ectopically
implanted [1,2]. Lastly, the ESCs genome is easily modifiable with
various mutagenesis techniques. Because ESCs and induced
pluripotent stem cells (iPS) are valuable resources for modeling
human diseases in vitro and in vivo as well as a potential source for cell
replacement therapy, major efforts are ongoing to decipher the
molecular determinants regulating the cardinal features pertaining
to these cells, such as self-renewal, pluripotency, multilineage
differentiation and tumorigenic potential.
ESCs are capable of being maintained undifferentiated in vitro in
the presence of LIF and BMP signaling [8]. Upon removal of self-
renewal signals (e.g. LIF), ESCs will differentiate in vitro into
aggregated structures called ‘‘embryoid bodies’’ or ‘‘EB’’. ESC
differentiation into EB occurs in an ordered manner, with the
generation of derivatives from the 3 germ layers [9]. This feature
of in vitro ESC differentiation seems to recapitulate, in a
spatiotemporal manner, several of the differentiation processes
observed in vivo (i.e., normal embryonic development [10]).
Moreover, ESC differentiation into endoderm, mesoderm, and
ectoderm is highly regulated and correlates with expression of a
panel of specific markers, which can be used to characterize the
extent of the differentiation process at the molecular level [11].
Networks regulating ESC fate
Although several proteins involved in signaling, transcriptional
regulation and chromatin modification are implicated in ESC
activity, we still do not understand all genetic hierarchies dictating
ESC fate [12–15]. Recent studies have also documented a function
for non-coding RNAs such as microRNAs and lincRNAs in ESC
behavior [16,17].
Aside from these large classes of determinants, sequence
comparison analyses suggest that other elements of the mamma-
lian genome might be regulating biological functions, including
ESC behavior. Among these elements are 480 segments of
.200 bp termed ‘‘ultraconserved elements’’, characterized by
100% sequence conservation (higher degree of conservation than
PLoS Genetics | www.plosgenetics.org 1 December 2010 | Volume 6 | Issue 12 | e1001241protein-coding regions) between human, mouse, and rat genome
[18]. Of these ‘‘ultraconserved’’ elements, more than 50% show
no evidence of transcription, while others overlap with protein
coding genes [18]. These sequences are enriched for homeodo-
main-binding modules, which is intriguing considering the
important role of homeodomain transcription factors in ESC
pluripotency and developmental processes [19]. Finally, although
evolutionary conserved sequences may pinpoint functionally
important genomic regions, other crucial elements may lack
evolutionary constraints [20].
Functional genomics in mammalian stem cells
Several large-scale functional genomics initiatives are currently
ongoing to understand the molecular bases of embryonic stem
cells. These include single gene inactivation (or alleles generation)
using diverse strategies such as chemically-induced point muta-
tions [21], gene/exon trapping (e.g., the international gene trap
consortium: www.genetrap.org) and homologous recombination
(The comprehensive knockout mouse project consortium: [22]). A
repository for KOMP now exists (www.komp.org) in which 8500
genes are being targeted (several in conditional alleles) within
relatively short periods of time. This repository contains several
available lines from other initiatives. As a result, in mouse, most
protein-coding genes will be deleted and available, many of them
as conditional alleles, within the coming years. While these
collections represent an outstanding resource for the community,
they nonetheless leave a significant proportion of the ‘‘functional
genome’’ unexplored. Moreover they fail to examine synthetic
interaction between gene neighbours.
To complement existing resources that explore functional
elements in the mammalian stem cell genomes, we have applied
our recently developed retroviral tools to create a collection of
ESC with nested chromosomal deletions [23]. Here we document
the generation of DelES (Deletion in ES cells) library, which
contains more than a thousand independent ESC clones highly
enriched in chromosomal deletions and representing a large
coverage of the mouse genome. Evidence is provided to
demonstrate that a large proportion of these clones are competent
in functional assays. A complementary method was also optimize
to introduce, at high efficiency, a series of selectable marker genes
in the backbone of BACs in order to rescue the inability of selected
ESC clones to form embryoid bodies in vitro. This first validation
allowed the identification of a novel gene essential for EB
formation. In addition, a database was created (http://bioinfo.
iric.ca/deles) to assist in sample management and to compile and
interpret all genetic and phenotypic data related to the collection
of clones. This database will facilitate the search for genomic
regions regulating the ESC activity and the further design of
rescue experiments. The library of ESC clones described herein
thus has the added potential of deciphering novel determinants
involved in ESC activity. On that basis, it is highly complementary
to other international functional genomics initiatives.
Results
Generation and molecular characterization of DelES
resource
In order to generate a library of ESC clones containing nested
chromosomal deletions (DelES library), we used a retroviral-based
method that exploits Cre-loxP technology as described [23]
(summarized in Figure 1A). Assisted by robotic cell culture
manipulation, we upscaled the previously described procedure to
generate the DelES collection (Figure 1B, see also Text S1 and
Table S1). Statistics about the various groups of clones in DelES
(primary, secondary and tertiary clones) and the types of
chromosome rearrangements (e.g., nested chromosomal deletions)
are detailed in Figure 1C. A total of 4929 G418
R tertiary clones
(i.e., ESC clones harboring recombination events are selected with
geneticin) originating from 156 anchor sites (i.e., families) were
isolated (Figure 1C and Table S1). Of these, 33.8% (n=1670)
were sensitive to puromycin (puro
S) of which 78.3% (n=1307)
were cryopreserved in 96 well plates. Previous work has shown an
expected 80% chromosomal deletion rate in puro
S clones [23].
When further characterized for proviral integration patterns by
Southern blot analyses, we found that these 1307 independent
clones harbored in fact 512 distinct chromosomal rearrangements
(referred to as sub-families, not shown). Moreover, each family,
characterized by a common anchor site, presented an average of
5.39 (range 1 to 20) distinct chromosomal rearrangements (Table
S2). So far 423 deletions of which 294 are unique have been
mapped by inverse or ligation mediated PCR (Figure 2A),
representing 25.4% of the mouse genome (Figure 2B). The
genomic coverage varies by chromosome, with no identified
deletions on chromosomes 19, X or Y; limited coverage of
chromosomes 8 and 13 (8.7% and 4.2%, respectively); and
approximately 50% coverage of chromosomes 6 and 18
(Figure 2B). On average, there is approximately 23% genome
coverage per autosome. Deletion sizes range from 736 bp to
100.79 Mb, with a median of 1.61 Mb (average size: 4.95 Mb)
(Figure 2C), and vary according to the chromosome (Table S3).
Chromosomes 1, 8 and 16 are characterized by many small
deletions, while chromosomes 18 and 14 have a few large deletions
(DelES database, http://bioinfo.iric.ca/deles).
As depicted in Figure 1A and detailed earlier [23], deletions are
typically characterized by G418
R clones which have lost the
hygromycin and the puromycin genes. Interestingly, we found 29
families in which none of the G418
R clones had lost hygromycin
and/or puromycin resistance genes. One possibility that could
explain this observation is that the anchor virus may have
integrated in the vicinity of haplolethal loci. The Table S4
provides a list of genes present in the vicinity of 9 independent
anchor loci that are not associated with chromosomal deletions




2 clones). A literature search was performed to
identify candidate genes in these regions which are known or
predicted to be haploinsufficient or imprinted (in red). On average,
,1 haploinsufficient/imprinted candidate gene was identified per
Author Summary
Stem cells have received considerable public attention in
part because of their potential application in regenerative
therapies. Stem cells can be operationally defined as cells
that have the unique property to self-renew, as well as to
generate more differentiated progeny (differentiation).
However, much remains to be learned about the genes
regulating stem cell differentiation and renewal, their
relationship to each other, and the signaling pathways that
control their expression and/or activity. In this paper, we
present a new resource developed in our laboratory, called
DelES, for chromosomal deletion in ES cells. By reinserting
deleted DNA fragments in a set of ESC clones harboring
nested chromosomal deletions, we identified the Rps14
gene as being haploinsufficient for embryoid body
formation. We think that our library of more than 1,300
clones represents a new resource that should allow the
identification of genes and other elements that are
essential for stem cell activity.
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directional anchor site (Table S4). These candidate genes, alone or
in combination with other genes or non-coding elements within
these regions, could potentially regulate essential cellular functions
or specific characteristics of ESCs and thus cannot be maintained
in a heterozygous state.
Taken together, these results reveal that close to 300
independent deletions exhibiting a genome-wide distribution have
been confirmed in the DelES collection.
Genomic coverage of DelES
To evaluate the content of DelES genomic coverage, genes
included in currently mapped deletions were classified according
to their gene ontology (GO) terms. Gene ontology analysis of
molecular functions of the 7083 mapped deleted genes revealed
similar percentages in each category to that obtained for all
annotated MGI genes (with known functions) (data not shown).
When genes were grouped by molecular function, the most
abundant group was genes with signal transduction activity,
followed by transcriptional regulation and nucleic acid binding
activities (data not shown).
Distribution of some key genomic elements covered by mapped
deletions, such as protein-coding genes, CpG islands, miRNA,
ultraconserved elements, lincRNA, LINE/SINE elements, cancer-
related genes and large deletions associated with cancers was
evaluated (Figure 3, Table S5). For this analysis, elements found in
all of DelES’s mapped deletions were compared to publicly
available genome-wide entries for each category. Percentages
represent ratios between the number of observed elements (found
in DelES mapped deletions) and the number of reported entries
(assuming random distribution of elements), based on the current
genome coverage of DelES (25.4%). Interestingly, mapped
deletions cover close to 100% of each category: genes (7083/
7348), CpG islands (4265/3515), miRNA (128/139), lincRNA
Figure 1. Creation of DelES resource. (A) The engineering methodology is comprised of two compatible retroviruses each containing a loxP
sequence. The anchor virus (A1) includes a functional puromycin (puro) gene and a truncated neomycin (neo ATG-less) gene. The saturation virus (S1)
includes a hygromycin (hygro) gene and a Pgk-ATG (murine phosphoglycerate kinase) promoter cassette that, following Cre recombination, drives
expression of a functional neomycin gene. ESC clones harboring recombination events are selected with geneticin (G418). Chromosomal deletions
lead to the concomitant loss of the puromycin and hygromycin genes. LTR, long terminal repeat; SIN, long terminal repeat containing a deletion in
the U3 region. (B) Three steps were followed to generate the ESC clones in DelES: i) isolation of puromycin-resistant (puro
R) clones containing a single
A1 virus integration, referred to as primary clones; ii) infection of individual primary clones with a low titer S1 virus to generate puro
R and hygromycin
resistant (hygro
R) polyclonal populations of secondary clones; iii) transient Cre expression and isolation of G418-resistant (G418
R) recombinant tertiary
clones. The group of tertiary clones originating from a specific primary clone and secondary clone population is referred to as a family. (C) Summary
of statistics relative to cryopreserved clones. CPC, Cherry-picked clones; MPL, master plate.
doi:10.1371/journal.pgen.1001241.g001
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(648571/602886), cancer related genes (108/104) and large
cancer-associate deletions (5/7). Thus, several categories of
protein-coding and non-coding sequences are well represented in
deletions that are currently mapped. Moreover, clustering of
specific genomic determinants has been reported [18,24–26]. As
Figure 2. Molecular characterization of DelES clones. (A) Karyoview representation of anchor virus integration site and coverage of the longest
deletion (red bar) mapped for each family of clones. The arrow indicates the predicted deletion orientation relative to the specific anchor site.
(B) Genome-wide coverage of deletions mapped in DelES clones. Haploid deletions are mapped to most autosomes, covering more than 25% of the
murinegenome. (C)Boxplot representingthesizedistributionassociatedto95%ofmappeddeletions.Averageandmedian deletionsizesareindicated.
doi:10.1371/journal.pgen.1001241.g002
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elements were deleted in DelES clones (highlighted in red, Table
S5). Deletions of entire clusters represent another strength of
DelES, as it presents the opportunity to analyze synthetic
interactions between family members and to study possible
functional redundancies.
Organization of DelES collection in a public database
In order to facilitate access to the DelES collection and all clone-
specific information, a database accessible through a web interface
offering data mining tools was constructed (Figure S2, http://
bioinfo.iric.ca/deles). A detailed explanation of the content of the
interface can be found in Figure S2 and in Text S1.
Taken as a whole, the DelES database allows for the
management of biological material (Plate tab) and facilitates the
search for ESC clones through phenotypic or genetic annotations
(Selection tab). The results of the search are directly linked to the
complete data sets (Families tab, Figure S2). Phenotypic informa-
tion can rapidly be associated to a graphical representation (Screen
tab) of the mapped deletion including the implicated genomic
features and BACs available for complementation studies (e.g.,
family 9).
Quality control of DelES clones
Primary and tertiary clones in the DelES collection are
distributed and frozen in 96 well plates. Localization of each
clone within plates can be directly visualized online under the plate
collection tab (http://bioinfo.iric.ca/deles). Colored well images
indicate the presence of suspected undesired chromosomal
anomalies and rearrangements (e.g., detection of hygromycin
gene). Master plates containing DelES collection were thawed
once to rule out microbial contamination and to determine the
proportion of clones which proliferate normally (e.g. high
proportion of Ki67
+ cells) or those which express high levels of
alkaline phosphatase activity, typically associated with undifferen-
tiated ESC.
Figure 4A shows that nine percent of the puro
S hygro
2 tertiary
clones showed low alkaline phosphatase activity (scores ,3;
families with clusters of clones with low AP activity are identified
as r in Figure 4), suggesting that their pluripotent capabilities were
impaired. Specific genomic features covered by the nested
deletions in these cells may be responsible for maintaining the
pluripotent state of ESCs. This possibility will be investigated
separately as part of a screen which will include multilineage
differentiation assays and additional markers of pluripotency, such
as Oct4.
Figure 4B shows that 14% of puro
S hygro
2 tertiary clones
presented low levels (,60%) of Ki67
+ cells. Clusters of clones
presenting altered proliferation status (Ki67
+ ,60%) were
observed in 17 families (identified as y, Figure 4). The quan-
tification of Ki67 expression was highly correlated with observed
cell proliferation rate measured by flow cytometry using calibrated
beads (data not shown) and batch collection of clones based on cell
density or expansion (i.e. clones collected in first batch ‘‘A’’ expand
faster than those in last batch ‘‘D’’ which were the slowest to
expand; see Figure S1 and Text S1). This observation was also
validated by a cell density assay which estimated ESC colony
number one day after plating (data not shown). Unfortunalely,
clones with very low proportion of Ki67
+ cells are easily lost upon
freeze thaw procedures and are difficult to maintain in the
collection (S.F., personnal observation).
Overall, the vast majority of clones in the DelES collection
express high levels of alkaline phosphatase; they proliferate
normally; they support freeze-thaw procedures and they appear
free of microbial contaminant. Clones can be recovered
individually (all frozen in 96 well plates and individually) from
several freeze thaw cycles. This suggests that DelES clones might
be amenable to different functional screening procedures and that
they can be validated separately. However, clones with low Ki67
activity are difficult to maintain.
Functional screen of DelES: in vitro EB formation
Using control (parental) R1 ESCs, we observed a strong
correlation between the number of EB generated in culture and
the number of ESCs plated (Figure 5A). This value was reliable
when cell density was above 5% (S.F., Figure 5A and data not
shown). This observation was exploited to develop a functional
screen in which each clone from DelES was individually seeded in
two 96 well plates, one with LIF for estimation of ESC colony
numbers (seeding density in Figure 5A) and the other without LIF
for EB differentiation (Figure 5B), aiming to identify minimal
deleted regions that cause a block in normal EB development.
Three criteria were used to identify clones and families with EB
formation anomalies: 1) clones were only considered if cell density
was above 5% (45% of clones); 2) EB formation was considered
abnormal in a tertiary clone if EB number was below one fifth of
that detected in the corresponding primary clone (16.4% of
clones); 3) families with EB phenotype were selected only if all
clones with deletions exceeding that of the minimal deleted region
also show the phenotype (see Figure 5C for selected vs rejected
families). The high percentage of clones that were eliminated
based on the first criteria reflects the wide distribution of cells (e.g.,
less than 1% to over 10%) recovered after freeze-thaw process (see
also Methods for methylene blue staining). Using criteria described
Figure 3. Genomic coverage of DelES. According to a hypothetical
random distribution of elements throughout the murine genome, the
indicated features mapped in DelES deletions were proportionally
represented. Numbers used for the calculation were extracted from the
following sources: MGI [49] for genes, miRBase13 [43] for miRNAs,
Ensembl for CpG islands and LINE/SINE [44], the Wellcome Trust Sanger
Institute website [50] for cancer related genes and large deletions
linked to cancer, and a previous report [18] for ultraconserved (UC)
elements.
doi:10.1371/journal.pgen.1001241.g003
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potentially interesting for the future identification of EB formation
determinants (Figure 5D and http://bioinfo.iric.ca/deles for
details of each clones in the selected families. See also Table S6
for primary screen data).
Several tertiary clones from five randomly selected families (9*,
5061*, 5035, 5214, 5238; *=families with phenotype) were tested
for in vitro EB formation using standard assays in 60 mm dish in
duplicate experiments. Corresponding primary clones were
included in these validation experiments. These studies showed a
concordance rate of 78% (28 out of 36 tested) between tertiary
clones tested in validation experiments and the results obtained in
the primary screen. In total, 3 of the 5 tested families were
validated including two (9, 5061) which show putative phenotype
associated with a minimal deletion region, located on chromosome
11 and 18 for family 5061 and 9, respectively (see http://bioinfo.
iric.ca/deles) From this assay, it thus appears that the primary
screen underestimates the frequency of families which include
clones with EB differentiation phenotype. Consistent with this, our
15.6% hit rate is below that previously observed in our pilot
studies of nine families (33% of families showed EB differentiation
phenotype [23].
Complementation studies of DelES family 9
DelES family 9 was chosen as the prototype for complemen-
tation studies since clones of this family harboring large deletions
are unable to differentiate into embryoid bodies. Of importance
for the complementation studies described below, the frequency of
EB formation in clones containing large deletions was lower than 1
in 5000 (i.e. 1 EB for 5000 cell plated). The minimal region
responsible for the abnormal phenotype (e.g., red line in Figure 6A)
was mapped between the breakpoints of tertiary clones 9–35
(736 bp deletion, normal in vitro differentiation) and 9–37
(4.3 Mbp deletion) (Figure 6A). This minimal deleted region
contains 30 known protein-coding genes and can be covered by 20
contiguous bacterial artificial chromosomes BACs (Figure 6A).
These 20 BACs were modified for selection in ESC using a
strategy that we adapted from existing recombineering systems to
allow for the introduction of selectable marker gene into the
chloramphenicol resistance sequence present in the backbone of
the different BACs [27]. Details about this method, called
SelectaBAC, are provided in Text S1 and in Figure S3.
Two independent tertiary clones with EB formation phenotype,
9–37 and 9–18, were transfected with each of the 20 BAC
constructs separately and assayed for embryoid body formation.
Interestingly, none of the BAC but one -RP23-143E19- led to a
complete rescue of the differentiation defect of clone 9–37, and
partial rescue of clone 9–18 which contains a larger deletion
(Figure 6B).
To validate the presence of transfected BAC in complemented
ESCs, metaphase fluorescence in-situ hybridization (FISH) was
conducted using two differentially labeled probes: the first being
RP23-143E19 itself and the second a control BAC which maps
adjacent to the deleted region (Figure 6C, lower-left panel).
Transfected clones were compared with untransfected tertiary
controls and R1 ESCs. As expected, normal R1 ESCs had two
pairs of closely localized signals, corresponding to the intact
mitotic chromosomes 18 (Figure 6C). Haploid deletions were
Figure 4. Quality control of DelES clones. 1080 puro
S hygro
2 tertiary clones, grouped in 89 independent families, were analyzed for alkaline
phosphatase (AP) staining (self-renewal/pluripotency) and expression of Ki67 (proliferation). (A) AP scores, ranging from 1 to 5 (1=weak staining;
5=strong staining), represent the mean values of one experiment performed with two independent cell densities. Approximately 9% of clones (9
families with more than two clones) demonstrated an abnormal phenotype for this assay (dashed bar represents the abnormal phenotype cutoff,
arbitrarily set at 3). (B) Ki67 values are expressed as the percentage of Ki67-positive cells, gated on viable cell populations by flow cytometry.
Approximately 14% of the clones (17 families with more than 2 clones) presented a proliferation defect (dashed bar represents the abnormal
proliferation cutoff, stringently set at 60% Ki67-expressing cells). Families with at least 3 clones harboring an abnormal phenotype are marked by the
following symbols: r or y, for AP or Ki67 category, respectively.
doi:10.1371/journal.pgen.1001241.g004
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pair of RP23-143E19 signals, closely-localized to one of the two
pairs of control BAC signals. When clones 9–37 and 9–18 were
transfected with the BAC of interest, 86% and 69% of cells
counted displayed a pattern consistent with stable integration of
the BAC (Figure 6C, upper and lower-right panels). This pattern
corresponds to two pairs of RP23-143E19 signals, one on
chromosome 18 identified by the control BAC signals and another
on a different chromosome (not identified by the control BAC
signals). Twelve percent of transfected 9–37 clones had larger and
more intense red signals (RP23-143E19), which potentially
indicates multiple integrations within the same chromosomal
region (data not shown).
Control primary 9 clone, tertiary clones 9–18 and 9–37 and
BAC-complemented tertiary clones 9–18 and 9–37 were injected
separately into blastocysts or aggregated with CD1 morulas to
evaluate their contribution to developing embryo. Mouse
embryos, at E9.5 and E14.5 were analyzed for the presence of
the neomycin gene (A1 provirus or A1-S1 recombined proviruses)
by PCR, whereas the level of chimerism in newborns was
estimated by coat color variation (Figure 6D). As previously
reported for the clone 9–18 [23], the unmodified tertiary ESC
clone 9–37 also failed to contribute to tissue chimerism in early
embryos or newborn mice (Figure 6D). In contrast, primary clone
9, used as a positive control, contributed to tissue chimerism of 17
out of 55 mice analyzed (Figure 6D). RP23-143E19-transfected
clone 9–37 also contributed to embryogenesis with tissue
chimerism in 36% and 18% of E14.5 and E9.5 embryos,
respectively, and in 4 of 12 newborn mice (Figure 6D). RP23-
143E19 transfected clone 9–18 also produced chimeric embryos
with a frequency of 50% at E14.5. Thus far, all chimeras (embryos
and newborn) appear phenotypically normal.
Confirmation that BAC-transfected ESCs contributed to the
chimeric embryos was obtained using Southern blot analyses
performed with gDNA extracted from fetal liver cells (Figure 6E).
For newborn and adult mice, percentage of tissue chimerism was
estimated at 80–95% and 10–35% for derivatives of primary clone
9 and BAC-complemented clone 9–37, respectively (Figure 6F).
Candidate gene evaluation for DelES family 9
A more detailed analysis of BAC RP23-143E19 reveals the
presence of four protein-coding genes: Ndst11, Tcof1, Rps14 and
Figure 5. Embryoid body formation screen. (A) Correlation of R1 control ESC seeding density versus embryoid body formation Linear regression
curve from control cells is shown 61 SD (B) Screen setup. Normalized master plates were thawed on irradiated feeder cells (MEF), before being
seeded on gelatinized plates prior to differentiation. After trypsinization, cells were plated in parallel, at equal volumes, in a gelatinized plate and in a
96 well plate containing semi-solid differentiation media. Cells in gelatinized plates were stained 24 hours after seeding with methylene blue
(seeding density) and EB number was assessed 8 days after seeding. (C) Phenotype identification of selected vs rejected families using criteria
described in text. (D) Phenotype identification in DelES families. (E) Distribution of family 9 clones in the screen setup described in B. Linear regression
curve from control cells is shown 61 SD. Outliers correspond to abnormal clones 9–18 and 9–37 which are used in complementation studies (Figure 6
and Figure 7). Red dot corresponds to primary clone 9.
doi:10.1371/journal.pgen.1001241.g005
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leading to a differentiation phenotype in family 9 tertiary clones. Schema adapted from UCSC Genome Browser (B) Embryoid body differentiation
assay following stable transfections of modified BACs covering the region of interest. Only BAC RP23-143E19 transfection could rescue the
differentiation defect in tertiary clones 9–37 (complete) and 9–18 (partial). Bars represent average EB number (transfected tertiary clones normalized
to control primary clone) from four independent transfections (n=4 tests per experiment). Complete and partial complementation leads to at least
300X and 100X EB over background EB number, respectively. (C) FISH analysis of BAC-transfected clones. Upper panel: representative metaphase FISH
images for selected clones. Lower left panel: FISH assay design, using two BACs as probes. RP23-323M5 is the control probe, which hybridizes outside
of the deleted region, and is labeled with a green fluorescent marker (G). The BAC of interest, RP23-143E19 is labeled with a red fluorescent marker
(R). Lower right panel: Complemented FISH signal reported as the proportion of cells which display a yellow (Red + Green: RG) signal combined with
Red and Green (R–G) signals over the total number of cells analyzed (n=100 interphase cells and n=10 metaphase cells). *, no RG+(R–G) cell
observed. (D) In vivo contribution of BAC-transfected and control clones to chimeric animals was evaluated by PCR for E9.5 and E14.5 embryos and by
coat color chimerism for adult mice. Values are represented as proportion of neomycin positive embryos over total number of embryos analyzed and
the proportion of adult chimeric mice over total number of newborns. Data related to non-transfected tertiary clone 9–18 has been previously
reported [23]. (E) Southern blot analysis of DNA extracted from chimeric dpc14.5 fetal livers. EcoRV restriction digest combined with a neo probe
revealed a 3 Kb and a 21 Kb fragment, corresponding to the primary anchor virus and modified BAC (EcoRV restriction sites in both insert and
backbone), respectively. (F) Pictures of representative embryos, chimeric mouse and table of average chimerism estimated by coat color
determination (newborn and adult mice). Dpc, days post coitum.
doi:10.1371/journal.pgen.1001241.g006
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the expression level of these genes in family 9 ESCs and EBs, with
or without BAC RP23-143E19 complementation. All four genes
analyzed are expressed in both control ESCs and EBs (primary 9)
with delta CT values ranging between 0.5 (Rps14, highest
expression) to 14.4 (Cd74, lowest expression) (data not shown).
Expression levels of all 4 genes in tertiary clone ESCs were about
half that observed in primary clone 9 (compare red bars, tertiary
clones to black bars, primary clone in Figure 7B). Upon BAC
transfection, expression levels of all four genes became either
comparable to -or exceeded- that found in the primary clone
(compare blue with black bars for undifferentiated ESCs and pink
with green bars for EBs in Figure 7B).
To gain insight on the contribution of selected elements present
on BAC RP23-143E19 to the observed phenotype, seven distinct
deletions were generated (Figure 7A). These included deletion of
all 4 protein-coding genes separately, the intergenic region
between Ndst1 and Rps14, a distal promoter to Ndst1 and a
lincRNA close to Rps14. Six out of the 7 constructs complemented
the EB formation defect observed in clone 9–37 to levels
comparable to control primary 9 clone. These 6 constructs
complemented clone 9–18 to levels equivalent to those detected
with the unmodified BAC (data not shown). Interestingly, the BAC
containing the small deletion (3.89 Kb) corresponding to the
Rps14 gene did not rescue the phenotype observed in clone 9–37
(Figure 7C) and clone 9–18 (data not shown), indicating that this
genomic region is haploinsufficient for EB formation.
Following this observation, Rps14 cDNA expression vector was
introduced in 9–37 and 9–18 ESC clones co-transfected with the
BAC RP23-143E19 construct no. 5 (lacking the Rps14 gene,
Figure 7A), to verify the possibility that a hidden genetic element
located within this small region that includes Rps14 was
responsible for the EB formation phenotype. Results from these
experiments indicated that 3 out of 8 clones isolated from 9–37
doubly transfected cells showed full complementation and 1 out of
4 clones from 9–18 cells was partially rescued (Figure 7D).
Expression analyses of these complemented clones revealed that all
4 protein-coding genes (Ndst1, Tcof1, Cd74 and Rps14) were
expressed at endogenous levels when compared to the primary
clone (data not shown). These results thus strongly suggest that
Rps14 is haploinsufficient for EB formation.
We then transfected Rps14 cDNA alone in 9–18 (data not
shown) and 9–37 tertiary clones to test if this gene is the sole
element responsible for the abnormal phenotype. Interestingly,
analyses of several transfected clones showed no complementation
with Rps14 cDNA (Figure 7E), raising the possibility that another
genetic element is necessary for complementation of DelES family
9. Nevertheless, these experiments show that Rps14 is not
sufficient, but required, to complement the EB formation defect
found in DelES family 9.
Discussion
The DelES library described herein contains a large collection
of independent ESC clones harboring chromosomal deletions
generated by a retroviral-based Cre-loxP system. Clonal analysis
revealed the presence of several independent deletions in this
library of which a significant proportion (close to 300) has been
mapped to various locations on mouse autosomes. With a median
deletion size of 1.61 megabase pairs, deletions cover more than
25% of the haploid murine genome. Overall, they include 7083
genes, of which one is reported to be haploinsufficient (Pml), seven
are predicted to be imprinted and 108 are associated with cancer.
In addition, 128 miRNAs, 241 ultraconserved elements, 470
lincRNAs and 648571 SINE/LINE elements are covered by the
deleted regions (Figure 3, Table S5). The first screening test for this
library consisted in analyzing EB formation upon LIF deprivation.
Fourteen families exhibited an abnormal phenotype. Pertinent
information of each clone in the collection is included in a public
database which was created to centralize information of this
expanding resource. This paper also includes the description of an
optimized BAC engineering strategy which greatly facilitates
complementation studies. This approach was thoroughly validated
by the successful rescue of the in vitro differentiation defect of one
family of clones, identifying Rps14 as a novel haploinsufficient gene
in EB formation from undifferentiated ESC.
To date, few genes, when disrupted, have generated overt in vitro
differentiation defects in ESCs. For example, ESCs that are
homozygous null for smad4 will generate much fewer cystic
embryoid bodies in vitro [28]. B-catenin activity also appears to
play a critical role in ESC differentiation since Apc homozygous
null ESCs fail to form neuroectodermal derivatives, although they
form (visceral and parietal) endoderm [29]. EB formation from
ext
2/2 (a tumor suppressor gene coding for an enzyme required
for the biosynthesis of heparin sulfate) ESCs is also defective with a
total absence of cavity formation, similar to the phenotype
observed with smad4 mutant cells [30]. Surprisingly, all of these
genes are known for their tumor-suppressive potential in various
human cancers: smad4, apc and ext1 in pancreatic, colon and bone
cancers, respectively. Although any generalization from these
findings would be premature, it is tempting to speculate that
additional tumor suppressor genes will be uncovered from
functional screens for genes that interfere with EB formation.
Recent studies would indicate that the ribosomal protein (RP)
coding gene Rps14 identified in this study may also perform tumor
suppressor functions in a preleukemia syndrome in humans
[31,32]. Indeed, this gene has been implicated in the human 5q-
syndrome (now called myelodysplastic syndrome with isolated
del(5q)), characterized by anemia and other cytopenias, as well as
other ribosomal protein coding genes that have been linked to
several blood differentiation disorders in human [32]. A p53-
dependent mechanism was identified lately has being responsible
of a mouse model of the 5q- syndrome. This model includes a
deletion of the Rps14 gene [33].
Ribosomes are made of large (60S) and small (40S) subunits
each preassembled in the nucleolus. The large subunit is made of 3
RNA species (5S, 5.8S and 28S) and about 49 different RPs. The
small subunit is made of a single 18S RNA molecule and
approximately 33 RPs [34]. Recent studies suggest that a common
mechanism involving defective ribosome biogenesis (also called
‘‘nucleolar stress’’) may underlie the cell differentiation defect
found in several human blood cell differentiation disorders, now
collectively called ‘‘ribosomopathies’’[35]. It was recently shown
that a RPS6 partial deficiency triggers a p53 response through
RPL11 interaction with MDM2, providing insights on molecular
effectors of the ‘‘ribosomal stress’’ response [36]. Based on our
findings with Rps14, future experiments will aim to better
characterize this RP-MDM2-P53 axis in ES cells differentiation
and to identify other genetic elements that contribute to our EB
formation phenotype.
The assessment of haploinsufficient synthetic interactions
between several contiguous genomic determinants, transcribed
or not, is a feature that distinguishes chromosomal deletion
engineering from other genome-wide reverse genetic approaches.
Distinctively based on a precisely localizable pair of retroviral
vectors, DelES is a resource complementary to other large scale
methodologies that allow the creation of nested chromosomal
deletions, such as: MICER [37] which is based on loxP-containing
Chromosome Deletions in ES Cells
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irradiation-induced deletions of integrated cassettes.
DelES clones offer many possibilities for reverse genetics since
they can be used to conduct in vitro differentiation assays, to
generate mutant animal models (chimeric, heterozygous, and
homozygous animals) [39] and potentially to create teratoma/
teratocarcinoma following heterotopic grafts into syngenic mice.
Moreover, engineered ESCs could be used to study dominant and
recessive (in vivo) chromosomal deletions associated with human
conditions with complex phenotypic profiles that cannot be
modeled using gene-specific mutagenesis approaches, such as
certain cancers (4 syntenic regions covered by DelES clones). For
this purpose, the correlation between chromosomal deletion size
and germ line transmission rate will need further investigation.
Conclusion
In conclusion, DelES is a new resource that offers a library of
ESC deletion clones, a BAC complementation system (Selecta-
BAC) and a comprehensive database. DelES benefits from
precisely localizable loxP-containing retroviral vectors which
accelerate the generation of segmental haploidy, and is comple-
mentary to other functional genomics resources. Its usefulness for
uncovering ESC fate determinants was demonstrated herein with
the identification of Rps14 as a novel haploinsufficient gene for EB
formation and early embryonic development. DelES is designed to
assess the roles of adjacent coding and non-coding sequences in
the mammalian genome, as well as their genetic interactions. Our
current efforts are to extend the coverage of mapped deletions in
DelES clones and to conduct additional functional screens, such as
cell cycle analysis, pluripotency assessment and hematopoietic
differentiation, to enrich our publicly available resource.
Methods
Generation of DelES collection
Viral producer cell lines and infection of target cells were
conducted as described [23]. Reagents used for Cre-loxP
recombination (A1 and S1 retroviruses, and pCX-Cre constructs)
were described previously [23]. Briefly, following R1 ESCs [40]
infection with anchor virus A1, approximately 288 puromycin
resistant primary clones were isolated. Q-PCR assays were
performed on genomic DNA to discard primary clones containing
presumptive trisomies. Five million primary clone cells (one clone
at a time) were infected with the saturation virus S1. Following
hygromycin selection, 10
7 cells from these secondary populations
(secondary population are derived from a single primary clone)
were electroporated with 25 ug of supercoiled pCX-Cre and
selected with G418, as described previously [23]. Up to 44 G418
R
tertiary clones were isolated per electroporated secondary
population and maintained in 96-well plates (labeled TER0xxx).
ESCs maintained in 96-well plates were either dissociated
manually or with a Biomek FX robot (Beckman Coulter) enclosed
in a biosafety cabinet. G418 resistant tertiary clones sensitive to
puromycin (puro
S) were arrayed together in 96-well plates (labeled
CPC0xxx). ‘‘Normalized’’ 96-well plates were also generated with
puro
S clones presenting similar proliferation rate for use in
functional assays. ESCs were cryopreserved at each stage of DelES
collection generation. A detailed description of the methods used
for the generation of DelES collection can be found in Text S1.
High-throughput functional assays
Detailed descriptions of the high-throughput assays performed
with puro
S clones arrayed in normalized plates are provided in
Text S1. The Alkaline Phosphatase Kit (Chemicon) was used
according to the manufacturer’s protocol. ESCs immunostained
with a PE-conjugated mouse anti-human Ki67 monoclonal
antibody (dilution 1:100, BD Biosciences) were analyzed by flow
cytometry. Cell counts were performed by flow cytometry using
TruCOUNT reference beads (BD Biosciences). Cell densities were
evaluated by methylene blue staining of ESC colonies.
Embryoid body formation screening
Gelatin-plated clones were seeded in 96 well plates (Sarstedt)
containing a semi-solid differentiation media and in parallel on a
new gelatinized plate (NUNC). EBs were counted following 8 days
of differentiation, while colonies on gelatinized plates were stained
with methylene blue twenty-four hours after seeding. Automated
quantification of the methylene blue stained area was used to
evaluate the cell input that produced the corresponding EB
number (Metamorph software). Criteria were established to
determine families with clones presenting abnormal EB formation
phenotypes, i.e. insufficient EB number or disaggregation. The
first was to exclude tertiary clones with low cell input values
(methylene blue ,5%, n=722 clones, 55.2%), which could be the
result of a defect in proliferation or cell adhesion, or simply a
technical issue. The number of EBs obtained for each tertiary
clone was compared to that of the corresponding primary clone.
Based on values obtained from larger format experiments, a
tertiary clone was called abnormal when it formed less than 20%
EBs relative to its primary clone (n=96 out of 585). Our final
criterion in identifying an abnormal family was to verify a
correlation between decreased EB formation with a larger deletion
size (where mapping was available).
DNA analyses
Genomic DNA (gDNA) from primary clones was extracted with
DNeasy 96 Blood & Tissue Kit (Qiagen protocol) and used for
Q-PCR screening of presumptive trisomies and mapping of
proviral integration sites (see below and Text S1). Genomic DNA
from primary clones, all tertiary clones (labeled TER0xxx), and
puro
S tertiary clones (labeled CPC0xxx or MPL0xxx) were
extracted using DNAzol (Invitrogen) by centrifugation in V-
bottom 96-well plates. Southern blot analyses were performed as
previously described [23]. To verify single integration of anchor
virus, primary clone gDNA was digested with BglII-BamHI
restriction enzymes and detection performed with a neomycin
Figure 7. Candidate gene evaluation of DelES family 9. (A) Genomic representation corresponding to the coverage of BAC RP23-143E19 and 7
deletion constructs. Schema adapted from UCSC Genome Browser (B) Expression analysis of candidate genes included in BAC RP23-143E19. Q-RT-PCR
results are represented as relative expression to that observed in family 9 primary clone (n=4 independent experiments in triplicates). Average DCt
per gene, for family 9 primary clone normalized with GAPDH expression levels, in ESCs and EBs, respectively; Ndst1: 10.85 and 6.55; Tcof1: 5.82 and
5.84; Rps14: 0.51 and 0.95; Cd74: 13.09 and 14.39. (C) Relative EB number derived from clone 9–37 cells previously transfected with BAC RP23-143E19
or each of the 7 deletion constructs presented in ‘‘A’’. Results are compared to those obtained with identical experiments performed with the
corresponding primary clone 9 (n=4 independent experiments, in duplicate; values for primary clone 9 adjusted to 100%). (D) EB number following
co-transfection of Rps14 deletion-containing BAC plus Rps14 cDNA. Values are represented as EB number of 3 transfected 9–37 clones and 1
transfected 9–18 clone over primary 9 clone levels. No EB was observed in cultures initiated with cells from tertiary 9–18 and 9–37 clones (*). (E) EB
number following transfection of Rps14 cDNA in tertiary clone 9–37. No EB was observed in this condition (*, n=11 clones analyzed).
doi:10.1371/journal.pgen.1001241.g007
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restriction digest), were either performed with a neomycin probe
to asses clonal diversity of rearrangements (e.g. clone classification
into sub-family) or with a hygromycin probe to confirm the loss of
hygromycin resistance gene. The presence/absence of hygromycin
gene was also monitored by Q-PCR assays (Text S1).
Mapping of proviral integration sites
Integration sites of the anchor virus were mapped in primary
clones by I-PCR or LM-PCR. Saturation virus integration sites
were mapped in tertiary clones by LM-PCR. The I-PCR
approach was previously described [23]. The LM-PCR strategy,
which relies on specific oligonucleotides described in Table S7,
was adapted from a published protocol [41] summarized in Text
S1. DNA sequences corresponding to proviral integration sites
were mapped using the BLAT alignment tool of the UCSC
Genome Browser (http://genome.ucsc.edu/, NCBI mouse Build
37) [42].
Construction of database
Biological material tracking and database
construction. Frozen cells, DNA, RNA, and maintenance
plates were identified with bar codes and specific labeling (details
provided in Text S1). A PostgreSQL database was set up in order
to maintain a centralized repository of the biological sample’s
storage locations, as well as to accumulate various types of results
and annotations. A web front-end running on a Webware for
Python application server was also developed to enable a user-
friendly access to the majority of the data contained in the
database. Numerous visualization, data-mining, and sample
management tools are still under development to provide a
flexible interface to query the annotations and to manage access to
the biological samples. Genome annotations presented in some of
DelES’ visualization tools as well as the gene searching capabilities
rely on locally deployed instances of mirBASE [43] (http://
microrna.sanger.ac.uk/) and Ensembl [44] (http://www.ensembl.
org/index.html). Published LincRNA [16] and Ultraconserved
Elements [18] annotations were also inserted into the DelES
database to facilitate integration. More functionalities of DelES
database are described in Text S1.
BAC engineering
BACs from the RP23 library (pBACe3.6 vector [45]) were
obtained from the BACPAC Resource Center (Children’s
Hospital Oakland Research Institute, Oakland, California) and
maintained in their original host strain DH10B in the presence
12 mg/ml chloramphenicol (unmodified BACs) or 25 mg/ml
kanamycin (retrofitted BACs). SelectaBAC retrofitting strategy,
adapted from published protocols [27,46,47], is described in the
Text S1.
BAC complementation
ESCs maintained on a feeder layer in 12-well plates were
transfected with 2 ug of circular BAC DNA using Lipofectamine
2000 Reagent (Invitrogen), according to manufacturer’s protocol.
Selection was started 48 h later, with the following concentration
of drugs maintained for at least 5 days: 1.5 ug/ml puromycin
(Sigma), or 150 ug/ml hygromycin (Roche), or 15 ug/ml
blasticidin (Sigma), or 30 ug/ml zeocin (Invitrogen). ESC diffe-
rentiation in embryoid bodies was performed in a LIF-deprived
semi-solid media, as described [11]. Genomic DNA from BAC
transfected clones was isolated using DNAzol, according to the
manufacturer’s instructions (Invitrogen). Southern blot detection
of transfected BAC DNA was performed using EcoRV digestion
and a probe specific to the neomycin gene, as described [48].
Total cellular RNA was isolated from BAC transfected clones
(undifferentiated ESCs or embryoid bodies) with Trizol (Invitro-
gen), according to the manufacturer’s instructions. Quantitative
RT-PCR assays were performed according to standard protocols
described in Text S1.
Generation of chimeric mice
Mouse chimeras were generated by the transgenic facility of
IRIC. ESCs [40] corresponding to primary clone no. 9, tertiary
clones 9–18 and 9–37 (with in vitro phenotype) and BAC-
transfected 9–18 and 9–37 clones (rescued in vitro phenotype),
were injected into C57BL/6 blastocysts or aggregated with CD1
morulas. Tertiary clone 9–18 results showed in Figure 6 are
already published [23]. ESCs contribution to chimeric embryos (at
E9.5 and E14.5) was evaluated by PCR using genomic DNA
extracted with a standard protocol (lysis with of 100 mM NaCl,
10 mM Tris pH 8.0, 25 mM EDTA pH 8.0, 0.5% SDS, and
2.5 ug/ml Proteinase K followed by phenol-chloroform extraction
and ethanol precipitation) or Sigma REDExtract-N-Amp Tissue
PCR kit (primers specific to the neomycin gene are described in
the Table S7). Southern blot analysis was performed as previously
described [48] with a neomycin probe and EcoRV-digested
genomic DNA isolated from E14.5 fetal livers using DNAzol
(Invitrogen). ESC contribution to adult mice was determined by
evaluation of the coat color chimerism.
FISH analysis
BACs RP23-143E19 and RP23-323M5 were labeled with
Spectrum Orange and Green fluorochromes, respectively, via
Nick Translation (Abbott Molecular Cat. No. 32-801300). BACs
have been tested both separately and together on mouse control
cells from Leukemia Cell Bank of Quebec. A minimum of one
hundred interphase nuclei and ten metaphases were evaluated per
sample and results are given as signal distribution percentages.
Supporting Information
Figure S1 Graphical representation of Ki67 values for each
puro
S tertiary clones grouped in normalized plate sets based on
proliferation rate. Puro
S tertiary ESC clones presenting similar
proliferation rate were arrayed together in 96-well plates: five
normalized plate sets were generated (A, B, B*, C, and D) based
on the timing of harvest (A=earliest collection, D, latest). Ki67
expressing cells were quantified by flow cytometry. Most tertiary
clones presenting ,60% Ki67
+ cells had a slow proliferation rate
(e.g. arrayed in plate set D) compared to other clones.
Found at: doi:10.1371/journal.pgen.1001241.s001 (0.34 MB TIF)
Figure S2 DelES interface. Overview of major functionalities of
DelES web database, available online at: http://bioinfo.iric.ca/
deles. The Families tab is depicted here as an example. It is divided
into 2 sub-sections: Karyoview and Families. The Karyoview sub-
section provides a graphical representation of the mapped primary
virus insertion sites as well as the orientation of the deletions for a
given family (color-coded icons, as indicated). Deleted chromo-
some portions are displayed as red lines to the left of the
ideograms. Especially noteworthy is the graphical representation
of the genomic context of the deletions. Currently available and
customizable tracks are: MGI genes, RP23 library BACs,
miRBASE miRNAs, lincRNAs and ultraconserved elements.
The Families sub-section presents most of the accumulated genetic
and phenotypic observations related to puro
S tertiary clones. Raw
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functionalities, see Text S1.
Found at: doi:10.1371/journal.pgen.1001241.s002 (2.58 MB TIF)
Figure S3 BAC engineering for DelES complementation. (A)
The SelactaBAC retrofitting strategy was optimized to introduce a
targeting vector (TV) containing a eukaryote (puromycin is
depicted) and a prokaryote (kanamycin; Kan) resistance gene into
the chroramphenicol (CM) gene of the BAC vector. This protocol
relies on the inducible expression (addition of L-arabinose and
temperature shift) of l phage proteins which mediate homologous
recombination events between the homology arms of the targeting
cassette (identified as A and B) and the BAC vector. Bacteria
containing the retrofitted BAC are resistant to kanamycin (Kan
R)
and sensitive to chloramphenicol (CM
S). (B) Southern blot
performed with BAC DNA extracted from bacteria. EcoRI
restriction digest combined with an external probe hybridizing
to the SacB gene of the BAC vector was used to detect proper
BAC modification. Fragments of 8.9 kb and 9.8 kb were observed
for the unmodified (wt CM
R) and the modified BACs (Mod. Kan
R
CM
S), respectively. Both fragments were observed with BAC DNA
extracted from mixed bacterial colonies (contain both modified
and unmodified BAC) (C) Southern blot performed with genomic
DNA extracted from ESCs stably transfected with a modified
BAC. NheI restriction digest (NheI sites in both BAC insert and
vector) combined with a neo probe revealed a 5.1 Kb and a 21 Kb
fragment, corresponding to the integration site of the primary
anchor virus and the modified BAC, respectively. (D) Combined
relative expression of Lmnb1, Iigp1, Isoc1 and Slc12a2, in tertiary
clone 9–37 following BAC transfections. Values are relative to
family 9 primary clone expression levels with standard error
(6SE), representative of 2 independent experiments performed in
duplicate reactions.
Found at: doi:10.1371/journal.pgen.1001241.s003 (1.34 MB TIF)
Table S1 Global statistics of DelES library generation.
Found at: doi:10.1371/journal.pgen.1001241.s004 (1.02 MB TIF)
Table S2 Molecular characterization details of DelES clones
used in functional assays. Listing of all DelES clones included in
the functional screen grouped in families according to anchor site,
and by subfamilies according to Southern blot fragment size. Also
included are batch numbers corresponding to normalized plates
used for functional screens and a summary of hygromycin
detection results evaluated by Southern blot and/or Q-PCR.
Found at: doi:10.1371/journal.pgen.1001241.s005 (0.18 MB XLS)
Table S3 Summary of deletions distribution. Number of
independent deletions, with average deletion size and median
per chromosome.
Found at: doi:10.1371/journal.pgen.1001241.s006 (1.14 MB TIF)
Table S4 Known or predicted haploinsufficient/imprinted
candidate genes present in the vicinity of DelES anchor loci that
are not associated with chromosomal deletions. Of the 29 families
characterized by the absence of puro
S or hygro
2 tertiary clones, 9
that had a minimum of 15 G418
R tertiary clones (80
th percentile of
distribution) were selected for analysis. Genes within a 1.61 Mb
window (DelES median deletion size) of each directional anchor
site are listed (hypothetical deletions). A literature search was
performed to identify candidate genes known or predicted to be
haploinsufficient or imprinted (in red). The search for haploinsuf-
ficient genes was performed by retrieving all abstracts from
Pubmed database that contain ‘‘haploinsuff* AND mouse’’ as
a query (August 11
th, 2009). Then, using a script as reported in
[51], a list of haploinsufficient genes was extracted from these
selected abstracts. The list of predicted imprinted genes was taken
from [52].
Found at: doi:10.1371/journal.pgen.1001241.s007 (1.20 MB TIF)
Table S5 Genomic content of DelES mapped deletions. List of
current DelES mapped families and elements included in the
family largest deletion. Clusters (genes, miRNA, ultraconserved
elements, lincRNA) are in represented in red and have been
identified by manually looking at all mapped families. Number of
genes with associated mouse phenotypes has been extracted from
MGI [53]. OMIM entries are based on human syntenic regions
[54].
Found at: doi:10.1371/journal.pgen.1001241.s008 (0.10 MB
XLS)
Table S6 Embryoid body screen raw data. Table presenting raw
data obtained for primary and tertiary clones EB formation
screening. EB number were counted manually and seeding
densities were obtained by an automated evaluation of the
methylene blue stained area.
Found at: doi:10.1371/journal.pgen.1001241.s009 (0.18 MB
XLS)
Table S7 List of oligonucleotides used in all reported assays.
Found at: doi:10.1371/journal.pgen.1001241.s010 (1.62 MB TIF)
Text S1 Supplemental Materials and Methods.
Found at: doi:10.1371/journal.pgen.1001241.s011 (0.09 MB
DOC)
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